Status:
COMPLETED
Comparison of Three Hypoabsortive Surgical Techniques for Treatment of Type IV Morbid Obesity
Lead Sponsor:
Hospital Universitari de Bellvitge
Conditions:
Bariatric Surgery
Morbid Obesity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Morbid obesity is the first non-traumatic cause of death in the western population and it is also progressively beginning to affect the developing countries. Bariatric surgery provides better results ...
Detailed Description
Morbid obesity is the first non-traumatic cause of death in the western population and it is also progressively beginning to affect the developing countries. Bariatric surgery provides better results ...
Eligibility Criteria
Inclusion
- Patients older than 18 and younger than 65 who fulfil bariatric surgery indications
- BMI between 50 and 60 kg / m2
- Patients with a good overall condition to perform a one step surgery
- Signing up of the informed consent for the study
- Patient suitable for laparoscopic surgery
Exclusion
- Previous bariatric surgery
- Two stage surgery
- Medical contraindication for a hypoabsorptive surgery due to previous pathology: inflammatory bowel disease, organ transplantation or candidate for a transplant, previous intestinal resection surgery
- Conversion to laparotomy
Key Trial Info
Start Date :
April 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 6 2023
Estimated Enrollment :
186 Patients enrolled
Trial Details
Trial ID
NCT04861961
Start Date
April 6 2021
End Date
November 6 2023
Last Update
December 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitary de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain, 08907